Tuesday, November 18, 2025 1:59:59 PM
Maybe I wasn't clear, I don't see an insider 'believer' cracking either, it would start a panic among the others.
It's my belief, and always has been they have to sell ABBIE, kits, license deals whatever, if they don't the pps will most likely return to previous levels ( mid trips ). I also believe the pps could very well triple from here ( or better ) should a verifiable Abbie deal be announced. Not only would it draw a ton of new eyes it will verify the validity of Abbie. So far we do not have that, and fewer and fewer people believe.
Regarding the 3 rd qtr, I was pleased to see this..
NET INCOME - 182,250
as opposed to 2nd qtr
NET INCOME (LOSS) (576,793)
gl
It's my belief, and always has been they have to sell ABBIE, kits, license deals whatever, if they don't the pps will most likely return to previous levels ( mid trips ). I also believe the pps could very well triple from here ( or better ) should a verifiable Abbie deal be announced. Not only would it draw a ton of new eyes it will verify the validity of Abbie. So far we do not have that, and fewer and fewer people believe.
Regarding the 3 rd qtr, I was pleased to see this..
NET INCOME - 182,250
as opposed to 2nd qtr
NET INCOME (LOSS) (576,793)
gl
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
